Nexalin Technology (NXL) Competitors $0.78 -0.02 (-2.61%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$0.81 +0.02 (+2.91%) As of 08/15/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. SURG, SPAI, MDAI, CTCX, RBOT, INO, PYPD, SRTS, APT, and QTIShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include SurgePays (SURG), Safe Pro Group (SPAI), Spectral AI (MDAI), Carmell (CTCX), Vicarious Surgical (RBOT), Inovio Pharmaceuticals (INO), PolyPid (PYPD), Sensus Healthcare (SRTS), Alpha Pro Tech (APT), and QT Imaging (QTI). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors SurgePays Safe Pro Group Spectral AI Carmell Vicarious Surgical Inovio Pharmaceuticals PolyPid Sensus Healthcare Alpha Pro Tech QT Imaging Nexalin Technology (NASDAQ:NXL) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends. Which has more volatility & risk, NXL or SURG? Nexalin Technology has a beta of 3.69, suggesting that its stock price is 269% more volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Do insiders & institutionals hold more shares of NXL or SURG? 0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 25.3% of Nexalin Technology shares are owned by company insiders. Comparatively, 30.5% of SurgePays shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, NXL or SURG? Nexalin Technology has higher earnings, but lower revenue than SurgePays. Nexalin Technology is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$170K80.36-$7.61M-$0.76-1.03SurgePays$60.88M0.69-$45.73M-$2.49-0.83 Does the media refer more to NXL or SURG? In the previous week, SurgePays had 11 more articles in the media than Nexalin Technology. MarketBeat recorded 13 mentions for SurgePays and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.43 beat SurgePays' score of 0.04 indicating that Nexalin Technology is being referred to more favorably in the media. Company Overall Sentiment Nexalin Technology Positive SurgePays Neutral Do analysts recommend NXL or SURG? Nexalin Technology currently has a consensus price target of $5.00, suggesting a potential upside of 537.59%. SurgePays has a consensus price target of $9.00, suggesting a potential upside of 334.78%. Given Nexalin Technology's higher probable upside, analysts clearly believe Nexalin Technology is more favorable than SurgePays.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NXL or SURG more profitable? SurgePays has a net margin of -133.85% compared to Nexalin Technology's net margin of -5,057.14%. Nexalin Technology's return on equity of -209.20% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-5,057.14% -209.20% -186.87% SurgePays -133.85%-333.87%-195.36% SummaryNexalin Technology beats SurgePays on 8 of the 14 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$13.66M$2.63B$22.12B$9.80BDividend YieldN/A1.56%2.82%4.13%P/E Ratio-1.0322.9927.9125.06Price / Sales80.3637.8441.6498.96Price / CashN/A45.0326.9458.67Price / Book2.316.255.636.18Net Income-$7.61M$33.68M$198.79M$265.11M7 Day Performance-12.87%0.34%0.92%4.22%1 Month Performance-31.81%-5.46%-2.46%0.77%1 Year Performance-19.65%32.86%27.80%24.69% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology3.1139 of 5 stars$0.78-2.6%$5.00+537.6%-19.7%$13.66M$170K-1.033Positive NewsShort Interest ↓SURGSurgePays3.3746 of 5 stars$2.97+1.9%$9.00+203.5%+0.0%$60.21M$60.88M-1.0640News CoverageEarnings ReportAnalyst DowngradeGap UpSPAISafe Pro Group0.7148 of 5 stars$3.94+2.1%$8.00+103.0%N/A$59.79M$2.17M-4.8711Earnings ReportGap DownMDAISpectral AI2.9855 of 5 stars$2.35-0.6%$3.50+49.2%+36.1%$59.50M$29.58M-4.3583News CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionGap UpCTCXCarmellN/A$2.70-4.6%N/A+166.7%$56.44M$32.84K0.0014Gap DownRBOTVicarious Surgical0.8026 of 5 stars$9.41+2.2%$8.50-9.6%+16.4%$55.79MN/A-0.90210News CoverageEarnings ReportAnalyst ForecastINOInovio Pharmaceuticals4.0439 of 5 stars$1.50+3.8%$8.80+488.6%-76.2%$54.46M$220K-0.47320News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpPYPDPolyPid2.8689 of 5 stars$3.32+2.8%$11.80+255.4%-8.0%$52.79MN/A-0.7780News CoverageEarnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionGap DownSRTSSensus Healthcare1.733 of 5 stars$3.17-0.3%$8.00+152.4%-48.3%$52.12M$41.81M-52.8340News CoverageAnalyst ForecastAnalyst RevisionAPTAlpha Pro Tech0.9047 of 5 stars$4.67-1.0%N/A-22.8%$50.68M$58.18M12.61120Negative NewsShort Interest ↑QTIQT ImagingN/A$1.85+0.5%N/A+300.4%$50.20M$4.00M0.00N/A Related Companies and Tools Related Companies SurgePays Alternatives Safe Pro Group Alternatives Spectral AI Alternatives Carmell Alternatives Vicarious Surgical Alternatives Inovio Pharmaceuticals Alternatives PolyPid Alternatives Sensus Healthcare Alternatives Alpha Pro Tech Alternatives QT Imaging Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access